跳至主要内容
临床试验/NCT00003159
NCT00003159已完成3 期

Randomized Trial of Surgical Resection With or Without Pre-Operative Chemotherapy in Patients With Operable Non-Small Cell Lung Cancer (NSCLC) of Any Stage

Medical Research Council4 个研究点 分布在 1 个国家目标入组 600 人开始时间: 1997年8月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
600
试验地点
4
主要终点
Survival

研究概览

简要总结

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if surgery is more effective with or without preoperative chemotherapy in treating non-small cell lung cancer.

PURPOSE: This randomized phase III trial is studying surgery and preoperative chemotherapy to see how well they work compared to surgery alone in treating patients with resectable non-small cell lung cancer.

详细描述

OBJECTIVES:

Primary

  • Compare the survival of patients with resectable non-small cell lung cancer treated with surgery with or without preoperative chemotherapy.

Secondary

  • Compare the quality of life of patients treated with these regimens.
  • Compare pre-randomization clinical and post-surgical pathological staging in patients treated with these regimens.
  • Compare resectability rates in patients treated with these regimens.
  • Compare time to and site of relapse in patients treated with these regimens.
  • Determine response in patients treated with preoperative chemotherapy.
  • Determine the adverse effects of preoperative chemotherapy in these patients.

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Treatment

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Survival

次要结局

  • Time to and site of relapse
  • Quality of life as measured by SF-36 questionnaire at baseline, 6 months, 12 months, and then annually thereafter
  • Adverse effects of chemotherapy
  • Extent of surgery
  • Tumor response to chemotherapy
  • Clinical and post-surgery pathological staging at pre-randomization
  • Resectability rates

研究者

申办方类型
Other Gov

研究点 (4)

Loading locations...

相似试验